This study is in progress, not accepting new patients
An Extension Study to Evaluate Safety and Efficacy of BMN 111 in Children With Achondroplasia
Summary
- Eligibility
- for people ages 15 months and up (full criteria)
- Location
- at Oakland, California and other locations
- Dates
- study startedcompletion around
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- BioMarin Pharmaceutical
- ID
- NCT03989947
- Phase
- Phase 2 Achondroplasia Research Study
- Study Type
- Interventional
- Participants
- About 73 people participating
- Last Updated